These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15905510)

  • 1. Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale.
    Abbott JR; Palmer GH; Kegerreis KA; Hetrick PF; Howard CJ; Hope JC; Brown WC
    J Immunol; 2005 Jun; 174(11):6702-15. PubMed ID: 15905510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypervariable region of Anaplasma marginale major surface protein 2 (MSP2) contains multiple immunodominant CD4+ T lymphocyte epitopes that elicit variant-specific proliferative and IFN-gamma responses in MSP2 vaccinates.
    Brown WC; Brayton KA; Styer CM; Palmer GH
    J Immunol; 2003 Apr; 170(7):3790-8. PubMed ID: 12646645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses.
    Brown WC; McGuire TC; Zhu D; Lewin HA; Sosnow J; Palmer GH
    J Immunol; 2001 Jan; 166(2):1114-24. PubMed ID: 11145692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD4+ T cell immunodominant Anaplasma marginale major surface protein 2 stimulates gammadelta T cell clones that express unique T cell receptors.
    Lahmers KK; Norimine J; Abrahamsen MS; Palmer GH; Brown WC
    J Leukoc Biol; 2005 Feb; 77(2):199-208. PubMed ID: 15522917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T lymphocytes from Anaplasma marginale major surface protein 2 (MSP2) vaccinees recognize naturally processed epitopes conserved in MSP3.
    Brown WC; Palmer GH; Brayton KA; Meeus PF; Barbet AF; Kegerreis KA; McGuire TC
    Infect Immun; 2004 Jun; 72(6):3688-92. PubMed ID: 15155686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplasma marginale major surface protein 2 CD4+-T-cell epitopes are evenly distributed in conserved and hypervariable regions (HVR), whereas linear B-cell epitopes are predominantly located in the HVR.
    Abbott JR; Palmer GH; Howard CJ; Hope JC; Brown WC
    Infect Immun; 2004 Dec; 72(12):7360-6. PubMed ID: 15557669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
    Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
    Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle.
    Okagawa T; Konnai S; Deringer JR; Ueti MW; Scoles GA; Murata S; Ohashi K; Brown WC
    Infect Immun; 2016 Oct; 84(10):2779-90. PubMed ID: 27430272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers.
    Norimine J; Han S; Brown WC
    Immunogenetics; 2006 Sep; 58(9):726-39. PubMed ID: 16924490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunization-induced antibody response to the Anaplasma marginale major surface protein 2 and its association with protective immunity.
    Noh SM; Zhuang Y; Futse JE; Brown WC; Brayton KA; Palmer GH
    Vaccine; 2010 May; 28(21):3741-7. PubMed ID: 20199762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid deletion of antigen-specific CD4+ T cells following infection represents a strategy of immune evasion and persistence for Anaplasma marginale.
    Han S; Norimine J; Palmer GH; Mwangi W; Lahmers KK; Brown WC
    J Immunol; 2008 Dec; 181(11):7759-69. PubMed ID: 19017965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.
    Brown WC; McGuire TC; Mwangi W; Kegerreis KA; Macmillan H; Lewin HA; Palmer GH
    Infect Immun; 2002 Oct; 70(10):5521-32. PubMed ID: 12228278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge.
    Brown WC; Shkap V; Zhu D; McGuire TC; Tuo W; McElwain TF; Palmer GH
    Infect Immun; 1998 Nov; 66(11):5406-13. PubMed ID: 9784551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of major surface protein 2 variants with conserved T-cell epitopes in Anaplasma centrale vaccinates.
    Shkap V; Molad T; Brayton KA; Brown WC; Palmer GH
    Infect Immun; 2002 Feb; 70(2):642-8. PubMed ID: 11796593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia.
    French DM; Brown WC; Palmer GH
    Infect Immun; 1999 Nov; 67(11):5834-40. PubMed ID: 10531237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.
    Ducken DR; Brown WC; Alperin DC; Brayton KA; Reif KE; Turse JE; Palmer GH; Noh SM
    PLoS One; 2015; 10(6):e0129309. PubMed ID: 26079491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Immunization-Induced Epitope-Specific CD4 T-Cell Response following Anaplasma marginale Infection Requires Presence of the T-Cell Epitope on the Pathogen and Is Not Associated with an Increase in Lymphocytes Expressing Known Regulatory Cell Phenotypes.
    Brown WC; Turse JE; Lawrence PK; Johnson WC; Scoles GA; Deringer JR; Sutten EL; Han S; Norimine J
    Clin Vaccine Immunol; 2015 Jul; 22(7):742-53. PubMed ID: 25924762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu.
    Araújo FR; Costa CM; Ramos CA; Farias TA; Souza II; Melo ES; Elisei C; Rosinha GM; Soares CO; Fragoso SP; Fonseca AH
    Mem Inst Oswaldo Cruz; 2008 Mar; 103(2):186-90. PubMed ID: 18425271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Structural Variation in Anaplasma marginale Msp2 Efficiently Generates Immune Escape Variants.
    Graça T; Paradiso L; Broschat SL; Noh SM; Palmer GH
    Infect Immun; 2015 Nov; 83(11):4178-84. PubMed ID: 26259814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subdominant antigens in bacterial vaccines: AM779 is subdominant in the Anaplasma marginale outer membrane vaccine but does not associate with protective immunity.
    Albarrak SM; Brown WC; Noh SM; Reif KE; Scoles GA; Turse JE; Norimine J; Ueti MW; Palmer GH
    PLoS One; 2012; 7(9):e46372. PubMed ID: 23029498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.